GH Research PLC (GHRS)

Currency in USD
14.70
-0.31(-2.07%)
Closed·
14.50-0.20(-1.36%)
·
Earnings results expected in 11 days
GHRS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.6115.22
52 wk Range
7.9819.51
Key Statistics
Prev. Close
15.01
Open
15.07
Day's Range
14.61-15.22
52 wk Range
7.98-19.51
Volume
182.19K
Average Volume (3m)
387.98K
1-Year Change
2.7254%
Book Value / Share
4.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GHRS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.73
Upside
+129.48%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

GH Research PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

GH Research Company Profile

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Compare GHRS to Peers and Sector

Metrics to compare
GHRS
Peers
Sector
Relationship
P/E Ratio
−21.2x−3.2x−0.5x
PEG Ratio
−2.680.000.00
Price/Book
3.1x2.5x2.6x
Price / LTM Sales
-1.7x3.3x
Upside (Analyst Target)
127.9%252.7%47.1%
Fair Value Upside
Unlock13.7%5.8%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 33.73
(+129.48% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Buy40.00+172.11%33.00Maintain23/01/2026
Needham
Buy29.00+97.28%19.00Maintain06/01/2026
Canaccord Genuity
Buy39.00+165.31%35.00Maintain06/01/2026
Citizens
Buy39.00+165.31%-Maintain06/01/2026
TD Cowen
Buy---Maintain05/01/2026

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.23 / -0.24
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.389
UOKA
-1.52%
31.13
ANPA
-50.03%
2.450
FLYX
-8.58%
0.49
ELPW
-30.26%
6.130
PHGE
-4.22%

FAQ

What Is the GH Research (GHRS) Share Price Today?

The live GH Research share price today is 14.70

What Stock Exchange Does GH Research (GHRS) Trade On?

GH Research is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for GH Research?

The stock symbol (also called a 'ticker') for GH Research is "GHRS."

What Is the Current GH Research Market Cap?

As of today, GH Research market capitalisation is 911.83M.

What Is GH Research's (GHRS) Earnings Per Share (TTM)?

The GH Research EPS is currently -0.73 (Trailing Twelve Months).

When Is the Next GH Research Earnings Date?

GH Research's next earnings report will be released on 26/02/2026.

Is GHRS a Buy or Sell From a Technical Analyst Perspective?

Based on today's GH Research moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has GH Research Stock Split?

GH Research has split 0 times. (See the GHRS stock split history page for full effective split date and price information.)

How Many Employees Does GH Research Have?

GH Research has 50 employees.

What is the current trading status of GH Research (GHRS)?

As of 15 Feb 2026, GH Research (GHRS) is trading at a price of 14.70, with a previous close of 15.01. The stock has fluctuated within a day range of 14.61 to 15.22, while its 52-week range spans from 7.98 to 19.51.

What Is GH Research (GHRS) Price Target According to Analysts?

The average 12-month price target for GH Research is USD33.73, with a high estimate of USD40 and a low estimate of USD25. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +129.48% Upside potential.

What Is the GHRS Premarket Price?

GHRS's last pre-market stock price is 15.10. The pre-market share volume is 60.00, and the stock has decreased by 0.09, or 0.60%.

What Is the GHRS After Hours Price?

GHRS's last after hours stock price is 14.50, the stock has decreased by -0.20, or -1.36%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.